Board Meetings for NEULANDLAB

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
NEULANDLABNeuland Laboratories Limited02 Nov 2018Financial ResultsTo consider and approve the financial results for the period ended September 30, 2018
NEULANDLABNeuland Laboratories Limited10 Aug 2018Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2018
NEULANDLABNeuland Laboratories Limited11 May 2018Financial ResultsTo consider and approve the financial results for the period ended March 31, 2018
NEULANDLABNeuland Laboratories Limited09 Apr 2018Fund RaisingA meeting of the Board of Directors of the Company is scheduled to be held on Monday, April 9, 2018, inter alia, to consider a proposal for raising funds by way of issuance of equity shares or equity linked securities such as warrants or convertible securities including but not limited to through preferential issue and/or qualified institutions placement or through any other permissible mode and/or combination thereof as may be considered appropriate, subject to approvals as may be required including approval of the Shareholders at a general meeting or through postal ballot and the same would be subject to such other regulatory/statutory approvals as may be applicable. Also, Trading Window for dealing in the securities of the Company shall remain closed till April 11, 2018.
NEULANDLABNeuland Laboratories Limited02 Feb 2018ResultsInter-alia, to consider and take on record the Un-audited financial results of the Company for the quarter ended December 31, 2017.
NEULANDLABNeuland Laboratories Limited22 Nov 2017ResultsNEULANDLAB : inter-alia to consider and take on record the Un-audited financial results of the Company for the quarter ended September 30, 2017
NEULANDLABNeuland Laboratories Limited11 Sept 2017Resultsinter-alia to consider and take on record the Un-audited financial results of the Company for the quarter ended June 30, 2017.
NEULANDLABNeuland Laboratories Limited12 May 2017Resultsinter-alia to consider and take on record the Audited financial results of the Company for the year ended March 31, 2017. Further the Trading Window for transactions in shares of the Company is closed from April 24, 2017 to May 14, 2017 (both days inclusive) and will be re-opened on May 15, 2017, inter alia, for the purpose of announcement of the Audited financial results of the Company for the year ended March 31, 2017.
NEULANDLABNeuland Laboratories Limited10 Feb 2017ResultsInter-alia to consider and take on record the Un-audited financial results of the Company for the quarter ended December 31, 2016.
NEULANDLABNeuland Laboratories Limited04 Nov 2016Results/Scheme of ArrangementThe Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held November 04, 2016 inter-alia, to consider and take on record the Un-audited financial results of the Company for the quarter ended September 30, 2016.The Company has now informed the Exchange that the Board of Directors inter alia, would also consider a draft Scheme of Amalgamation and Arrangement between Neuland Laboratories Limited ("the Company''), Neuland Health Sciences Private Limited and Neuland Pharma Research Private Limited .(Purpose Revised)
NEULANDLABNeuland Laboratories Limited04 Nov 2016ResultsInter-alia to consider and take on record the Un-audited financial results of the Company for the quarter ended September 30, 2016. Company would like to further inform that as per the provisions of the Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for transactions in shares of the Company is closed from October 14, 2016 to November 6, 2016 (both days inclusive), inter alia, for the purpose of announcement of the Un-audited financial results of the Company for the quarter ended September 30, 2016.
NEULANDLABNeuland Laboratories Limited27 Aug 2016Amalgamation/Mergerinter-alia, to consider a proposal to merge Neuland Health Sciences Private Limited (Holding Company) ( NHSPL ) and Neuland Pharma Research Private Limited (subsidiary of NHSPL) ( NPRPL ) with Neuland Laboratories Limited ( the Company ).
NEULANDLABNeuland Laboratories Limited12 Aug 2016ResultsInter-alia to consider and take on record the Un audited financial results of the Company for the quarter ended June 30, 2016.
NEULANDLABNeuland Laboratories Limited20 May 2016Results/Dividendinter-alia to consider and take on record the audited financial results of the Company for the year ended March 31, 2016. Further the Board of Directors also consider payment of dividend, if any, along with the audited financial results for the year ended March 31, 2016.
NEULANDLABNeuland Laboratories Limited03 Feb 2016ResultsInter-alia, to consider and take on record the un-audited financial results of the Company for the quarter ended December 31, 2015.
Showing page 4 of 7 (96 total items)